Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 5761 - 5768 of 12089 results
National Cyber Strategy Aims to Deter through Strength; Collaborate with Private Sector to Secure Cyberspace
September 28, 2018| Blog| Viewpoint
HHS Continues the “Sprint to Coordinated Care”
September 28, 2018| Blog| Viewpoint
The Massachusetts Division of Unemployment Assistance Issues Proposed Regulations Implementing EMAC Hardship Waivers
September 28, 2018| Blog| Viewpoint
State Regulation of Financial Institutions
September 27, 2018| Video| Viewpoint
The 2014 Overpayment Rule is Vacated: How We Got Here and Key Takeaways
September 26, 2018| Blog| Viewpoint
Peter Feldman Confirmed as Fifth Commissioner at CPSC, Ushering in a Republican Majority for First Time Since 2006
September 25, 2018| Blog| Viewpoint
Federal Circuit Upholds Trade Show Catalog As Prior Art in Nobel Biocare Servs. AG v. Instradent USA, Inc.
September 25, 2018| Blog| Viewpoint
Employing Medical Marijuana Users – Does Federal Law Give Employers a Pass?
September 25, 2018| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|